# Aquestive Therapeutics, Inc.: Form 8-K, filed Sep 17, 2026

- Company: [Aquestive Therapeutics, Inc.](/companies/aqst.md) (CIK 1398733)
- Form: 8-K
- Filed: 2026-09-17
- Accepted by EDGAR: Sep 17, 2026, 07:02 ET
- Period: 2026-09-14
- Accession: 0001398733-26-000044
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000044/aqst-20260914.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000044/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1398733/000139873326000044/aqst-20260914.htm

Filed Sep 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001398733-26-000044. Last ingested by Listed: Nov 13, 2026, 00:21 ET. No prices; not investment advice.